Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma
Clinical trial NCT02478164 · COMPLETED
Trial details
- NCT number
- NCT02478164
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-13
- Primary completion
- 2017-07-08
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.